HIPEC in patients with primary advanced ovarian cancer: Is there a role? A systematic review of short- and long-term outcomes.
Sign Up to like & getrecommendations! Published in 2018 at "Surgical oncology"
DOI: 10.1016/j.suronc.2018.05.006
Abstract: A systematic review of the studies where HIPEC combined with cytoreductive surgery was used in patients with primary advanced ovarian cancer was performed to understand is there a role for this treatment modality not only… read more here.
Keywords: primary advanced; systematic review; ovarian cancer; patients primary ... See more keywords
Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2023.2179483
Abstract: ABSTRACT Introduction Recurrent or primary advanced metastatic cervical cancer (R/M CC) has a poor prognosis with a 5-year-survival rate of 16.5%, demanding novel and improved therapies for the treatment of these patients. The first-line standard… read more here.
Keywords: primary advanced; oncology; investigational drugs; recurrent primary ... See more keywords
Robot-assisted sacrohysteropexy vs robot-assisted sacrocolpopexy in women with primary advanced apical prolapse: A retrospective cohort study
Sign Up to like & getrecommendations! Published in 2023 at "Journal of the Chinese Medical Association"
DOI: 10.1097/jcma.0000000000000882
Abstract: Background: This study aimed to evaluate the anatomic and clinical outcomes of robot-assisted sacrohysteropexy (RASH) against robot-assisted sacrocolpopexy (RASC) for the treatment of primary advanced apical prolapse. Methods: We conducted a retrospective cohort study of… read more here.
Keywords: primary advanced; prolapse; group; robot assisted ... See more keywords